Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: RADIATION: 68Ga-FAPI-46 PET/CT|BIOLOGICAL: Tumor samples analysis|BIOLOGICAL: Blood samples analysis: Circulating Tumor DNA
Sponsor: Institut Curie
Collaborators: Hoffmann-La Roche